High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations

Autor: Fürstenau, Moritz, Thus, Yvonne J., Robrecht, Sandra, Mellink, Clemens H. M., van der Kevie-Kersemaekers, Anne-Marie, Dubois, Julie, von Tresckow, Julia, Patz, Michaela, Gregor, Michael, Thornton, Patrick, Staber, Philipp B., Tadmor, Tamar, Levin, Mark-David, da Cunha-Bang, Caspar, Schneider, Christof, Poulsen, Christian Bjoern, Illmer, Thomas, Schöttker, Björn, Janssens, Ann, Christiansen, Ilse, Nösslinger, Thomas, Baumann, Michael, Hebart, Holger, Gaska, Tobias, Regelink, Josien C., Dompeling, Ellen C., Lindström, Vesa, Juliusson, Gunnar, Widmer, Anouk, Goede, Jeroen, Goldschmidt, Neta, Simon, Florian, De Silva, Nisha, Fink, Anna-Maria, Fischer, Kirsten, Wendtner, Clemens-Martin, Ritgen, Matthias, Brüggemann, Monika, Tausch, Eugen, Spaargaren, Marcel, Eldering, Eric, Stilgenbauer, Stephan, Niemann, Carsten U., Hallek, Michael, Eichhorst, Barbara, Kreuzer, Karl-Anton, Kater, Arnon P.

Publikováno v: In Blood 3 August 2023 142(5):446-459

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

An Unbiased CRISPR-Cas9 Screening Method for the Identification of Positive and Negative Regulatory Proteins of Cell Adhesion.

Autor: Thus YJ; Department of Pathology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam, The Netherlands.; Cancer Biology and Immunology - Target & Therapy Discovery, Cancer Center Amsterdam (CCA), Amsterdam, The Netherlands., De Rooij MFM; Department of Pathology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam, The Netherlands.; Cancer Biology and Immunology - Target & Therapy Discovery, Cancer Center Amsterdam (CCA), Amsterdam, The Netherlands., Beijersbergen RL; Division of Molecular Carcinogenesis and Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; NKI Robotics and Screening Center and Genomics Core Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Spaargaren M; Department of Pathology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam, The Netherlands.; Cancer Biology and Immunology - Target & Therapy Discovery, Cancer Center Amsterdam (CCA), Amsterdam, The Netherlands.

Publikováno v: Bio-protocol [Bio Protoc] 2022 Nov 05; Vol. 12 (21). Date of Electronic Publication: 2022 Nov 05 (Print Publication: 2022).